Free Trial

Tate & Lyle Interim Earnings Report

Tate & Lyle logo
GBX 520 -3.00 (-0.57%)
As of 12:45 PM Eastern

Tate & Lyle EPS Results

Actual EPS
GBX 17.70
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Tate & Lyle Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tate & Lyle Announcement Details

Quarter
Interim
Time
Before Market Opens

Conference Call Resources

Remove Ads

Tate & Lyle Earnings Headlines

Tate & Lyle price target lowered to 750 GBp from 800 GBp at Barclays
Barclays Keeps Their Hold Rating on Tate & Lyle (TATE)
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.
See More Tate & Lyle Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tate & Lyle? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tate & Lyle and other key companies, straight to your email.

About Tate & Lyle

Tate & Lyle (LON:TATE), together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; fibres; and stabilizers and functional systems. It also provides industrial starches; acidulants, such as citric acid; and commodities comprising corn gluten feed, meal, and corn oil. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

View Tate & Lyle Profile

More Earnings Resources from MarketBeat